Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rudolf Uher

Showing results (191-200 of 299) with videos related to

Pageof 30
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 13, 2012
Tumor necrosis factor and its targets in the inflammatory cytokine pathway are identified as putative transcriptomic biomarkers for escitalopram responseTimothy R Powell, Leonard C Schalkwyk, Andrew L Heffernan, et al.
Journal of Affective Disorders|February 19, 2026
Lam Employment Absence and Productivity Scale (LEAPS): Analysis of the minimal clinically important difference (MCID) in patients with major depressive disorder using data from the CAN-BIND-1 studyShiny Sachdeva, Victor W Li, Trisha Chakrabarty, et al.
BMJ Paediatrics Open|January 8, 2024
Preferences for virtual versus in-person mental and physical healthcare in Canada: a descriptive study from a cohort of youth and their parents enriched for severe mental illnessRaegan Mazurka, Emily Howes Vallis, Lucy Chen, et al.
The Journal of Clinical Psychiatry|June 20, 2020
Symptom Dimension of Interest-Activity Indicates Need for Aripiprazole Augmentation of Escitalopram in Major Depressive Disorder: A CAN-BIND-1 ReportRudolf Uher, Benicio N Frey, Lena C Quilty, et al.
Psychopharmacology|March 13, 2015
Exploring the role of drug-metabolising enzymes in antidepressant side effectsKaren Hodgson, Katherine E Tansey, Rudolf Uher, et al.
Journal of Psychopharmacology (Oxford, England)|January 14, 2014
Genetic predictors of antidepressant side effects: a grouped candidate gene approach in the Genome-Based Therapeutic Drugs for Depression (GENDEP) studyKaren Hodgson, Rudolf Uher, Andrew A Crawford, et al.
Translational Psychiatry|August 15, 2018
Genes associated with anhedonia: a new analysis in a large clinical trial (GENDEP)Hongyan Ren, Chiara Fabbri, Rudolf Uher, et al.
Lancet Regional Health. Americas|July 2, 2026
Developmental predictors of suicide attempts from childhood to early adulthood: a 15-year prospective cohort studyRodolfo Furlan Damiano, Daniel M Low, Lucas Toshio Ito, et al.
Psychiatry Research|December 10, 2019
Active behaviors and screen time in offspring of parents with major depressive disorder, bipolar disorder and schizophreniaAlex Pizzo, Vlad Drobinin, Andrea Sandstrom, et al.
Psychiatry Research|November 18, 2023
Predicting recurrence of major depressive episodes using the Depression Implicit Association Test: A Canadian biomarker integration network in depression (CAN-BIND) reportKaterina Rnic, Joelle LeMoult, Ivan J Torres, et al.
Pageof 30

Showing results (191-200 of 299) with videos related to

Sort By:
Pageof 30
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 13, 2012
Tumor necrosis factor and its targets in the inflammatory cytokine pathway are identified as putative transcriptomic biomarkers for escitalopram responseTimothy R Powell, Leonard C Schalkwyk, Andrew L Heffernan, et al.
Journal of Affective Disorders|February 19, 2026
Lam Employment Absence and Productivity Scale (LEAPS): Analysis of the minimal clinically important difference (MCID) in patients with major depressive disorder using data from the CAN-BIND-1 studyShiny Sachdeva, Victor W Li, Trisha Chakrabarty, et al.
BMJ Paediatrics Open|January 8, 2024
Preferences for virtual versus in-person mental and physical healthcare in Canada: a descriptive study from a cohort of youth and their parents enriched for severe mental illnessRaegan Mazurka, Emily Howes Vallis, Lucy Chen, et al.
The Journal of Clinical Psychiatry|June 20, 2020
Symptom Dimension of Interest-Activity Indicates Need for Aripiprazole Augmentation of Escitalopram in Major Depressive Disorder: A CAN-BIND-1 ReportRudolf Uher, Benicio N Frey, Lena C Quilty, et al.
Psychopharmacology|March 13, 2015
Exploring the role of drug-metabolising enzymes in antidepressant side effectsKaren Hodgson, Katherine E Tansey, Rudolf Uher, et al.
Journal of Psychopharmacology (Oxford, England)|January 14, 2014
Genetic predictors of antidepressant side effects: a grouped candidate gene approach in the Genome-Based Therapeutic Drugs for Depression (GENDEP) studyKaren Hodgson, Rudolf Uher, Andrew A Crawford, et al.
Translational Psychiatry|August 15, 2018
Genes associated with anhedonia: a new analysis in a large clinical trial (GENDEP)Hongyan Ren, Chiara Fabbri, Rudolf Uher, et al.
Lancet Regional Health. Americas|July 2, 2026
Developmental predictors of suicide attempts from childhood to early adulthood: a 15-year prospective cohort studyRodolfo Furlan Damiano, Daniel M Low, Lucas Toshio Ito, et al.
Psychiatry Research|December 10, 2019
Active behaviors and screen time in offspring of parents with major depressive disorder, bipolar disorder and schizophreniaAlex Pizzo, Vlad Drobinin, Andrea Sandstrom, et al.
Psychiatry Research|November 18, 2023
Predicting recurrence of major depressive episodes using the Depression Implicit Association Test: A Canadian biomarker integration network in depression (CAN-BIND) reportKaterina Rnic, Joelle LeMoult, Ivan J Torres, et al.
Pageof 30